Loading…
The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations
Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the s...
Saved in:
Published in: | Human reproduction (Oxford) 2000-05, Vol.15 (5), p.1079-1082 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3 |
---|---|
cites | |
container_end_page | 1082 |
container_issue | 5 |
container_start_page | 1079 |
container_title | Human reproduction (Oxford) |
container_volume | 15 |
creator | Thomas, K. Coughlin, L. Mannion, P.T. Haddad, N.G. |
description | Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P < 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up. |
doi_str_mv | 10.1093/humrep/15.5.1079 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71075191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/15.5.1079</oup_id><sourcerecordid>71075191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3</originalsourceid><addsrcrecordid>eNqNkEFv1DAQhS0EotvCnRPKAXFBae04duwjWgFFKuLQLaq4WBPH7hqSONhO1f33dZQV5chpRqPvzZt5CL0h-JxgSS_28xDMdEHYOcuDRj5DG1JzXFaU4edogysuSkI4OUGnMf7COLeCv0QnmRWUMr5BsNub4h762RTeFtt9D8Ohc1CkAHrvB0guFjAm1_ruUCQTkxvvCojFBCEtiuDnPDKFG60JyfUuHXJ_v4B3WezH-Aq9sNBH8_pYz9DN50-77WV59f3L1-3Hq1LXkqaywrXVUjJtKJYY2gqsaDkztbCVFKQRTSOxqLE1tGsE01zUrCNVJTm2uMWGnqH3694p-D9zPkANLmrT9zAaP0fV5KcZkSSDeAV18DEGY9UU3ADhoAhWS6xqjVURpphaYs2St8fdczuY7h_BmmMG3h0BiBp6G2DULj5xVEpSLdYfVszP0_-4livtYjIPf3kIvxVvaMPU5e1Pxdhu--369kf2eATzX5_S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71075191</pqid></control><display><type>article</type><title>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</title><source>Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)</source><creator>Thomas, K. ; Coughlin, L. ; Mannion, P.T. ; Haddad, N.G.</creator><creatorcontrib>Thomas, K. ; Coughlin, L. ; Mannion, P.T. ; Haddad, N.G.</creatorcontrib><description>Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P < 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up.</description><identifier>ISSN: 0268-1161</identifier><identifier>ISSN: 1460-2350</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/15.5.1079</identifier><identifier>PMID: 10783356</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Anti-Bacterial Agents - therapeutic use ; antibody ; Biological and medical sciences ; Chlamydia Infections - diagnosis ; Chlamydia Infections - drug therapy ; Chlamydia trachomatis ; Chlamydia trachomatis - immunology ; Endoscopy ; Enzyme-Linked Immunosorbent Assay - methods ; Fallopian Tube Diseases - epidemiology ; Fallopian Tube Diseases - microbiology ; Fallopian Tube Diseases - pathology ; Fallopian Tube Patency Tests ; Fallopian Tubes - pathology ; Female ; Fluorescent Antibody Technique, Indirect ; Genital system ; Humans ; hysterosalpingography ; Hysterosalpingography - methods ; Immunoglobulin G - blood ; Incidence ; Infertility, Female - epidemiology ; Infertility, Female - microbiology ; Infertility, Female - pathology ; Investigative techniques, diagnostic techniques (general aspects) ; Laparoscopy ; Medical sciences ; tubal damage</subject><ispartof>Human reproduction (Oxford), 2000-05, Vol.15 (5), p.1079-1082</ispartof><rights>European Society of Human Reproduction and Embryology 2000</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1399121$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10783356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomas, K.</creatorcontrib><creatorcontrib>Coughlin, L.</creatorcontrib><creatorcontrib>Mannion, P.T.</creatorcontrib><creatorcontrib>Haddad, N.G.</creatorcontrib><title>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</title><title>Human reproduction (Oxford)</title><addtitle>Hum. Reprod</addtitle><addtitle>Hum. Reprod</addtitle><description>Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P < 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibody</subject><subject>Biological and medical sciences</subject><subject>Chlamydia Infections - diagnosis</subject><subject>Chlamydia Infections - drug therapy</subject><subject>Chlamydia trachomatis</subject><subject>Chlamydia trachomatis - immunology</subject><subject>Endoscopy</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>Fallopian Tube Diseases - epidemiology</subject><subject>Fallopian Tube Diseases - microbiology</subject><subject>Fallopian Tube Diseases - pathology</subject><subject>Fallopian Tube Patency Tests</subject><subject>Fallopian Tubes - pathology</subject><subject>Female</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>Genital system</subject><subject>Humans</subject><subject>hysterosalpingography</subject><subject>Hysterosalpingography - methods</subject><subject>Immunoglobulin G - blood</subject><subject>Incidence</subject><subject>Infertility, Female - epidemiology</subject><subject>Infertility, Female - microbiology</subject><subject>Infertility, Female - pathology</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Laparoscopy</subject><subject>Medical sciences</subject><subject>tubal damage</subject><issn>0268-1161</issn><issn>1460-2350</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqNkEFv1DAQhS0EotvCnRPKAXFBae04duwjWgFFKuLQLaq4WBPH7hqSONhO1f33dZQV5chpRqPvzZt5CL0h-JxgSS_28xDMdEHYOcuDRj5DG1JzXFaU4edogysuSkI4OUGnMf7COLeCv0QnmRWUMr5BsNub4h762RTeFtt9D8Ohc1CkAHrvB0guFjAm1_ruUCQTkxvvCojFBCEtiuDnPDKFG60JyfUuHXJ_v4B3WezH-Aq9sNBH8_pYz9DN50-77WV59f3L1-3Hq1LXkqaywrXVUjJtKJYY2gqsaDkztbCVFKQRTSOxqLE1tGsE01zUrCNVJTm2uMWGnqH3694p-D9zPkANLmrT9zAaP0fV5KcZkSSDeAV18DEGY9UU3ADhoAhWS6xqjVURpphaYs2St8fdczuY7h_BmmMG3h0BiBp6G2DULj5xVEpSLdYfVszP0_-4livtYjIPf3kIvxVvaMPU5e1Pxdhu--369kf2eATzX5_S</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>Thomas, K.</creator><creator>Coughlin, L.</creator><creator>Mannion, P.T.</creator><creator>Haddad, N.G.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000501</creationdate><title>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</title><author>Thomas, K. ; Coughlin, L. ; Mannion, P.T. ; Haddad, N.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibody</topic><topic>Biological and medical sciences</topic><topic>Chlamydia Infections - diagnosis</topic><topic>Chlamydia Infections - drug therapy</topic><topic>Chlamydia trachomatis</topic><topic>Chlamydia trachomatis - immunology</topic><topic>Endoscopy</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>Fallopian Tube Diseases - epidemiology</topic><topic>Fallopian Tube Diseases - microbiology</topic><topic>Fallopian Tube Diseases - pathology</topic><topic>Fallopian Tube Patency Tests</topic><topic>Fallopian Tubes - pathology</topic><topic>Female</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>Genital system</topic><topic>Humans</topic><topic>hysterosalpingography</topic><topic>Hysterosalpingography - methods</topic><topic>Immunoglobulin G - blood</topic><topic>Incidence</topic><topic>Infertility, Female - epidemiology</topic><topic>Infertility, Female - microbiology</topic><topic>Infertility, Female - pathology</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Laparoscopy</topic><topic>Medical sciences</topic><topic>tubal damage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomas, K.</creatorcontrib><creatorcontrib>Coughlin, L.</creatorcontrib><creatorcontrib>Mannion, P.T.</creatorcontrib><creatorcontrib>Haddad, N.G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomas, K.</au><au>Coughlin, L.</au><au>Mannion, P.T.</au><au>Haddad, N.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum. Reprod</stitle><addtitle>Hum. Reprod</addtitle><date>2000-05-01</date><risdate>2000</risdate><volume>15</volume><issue>5</issue><spage>1079</spage><epage>1082</epage><pages>1079-1082</pages><issn>0268-1161</issn><issn>1460-2350</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P < 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>10783356</pmid><doi>10.1093/humrep/15.5.1079</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0268-1161 |
ispartof | Human reproduction (Oxford), 2000-05, Vol.15 (5), p.1079-1082 |
issn | 0268-1161 1460-2350 1460-2350 |
language | eng |
recordid | cdi_proquest_miscellaneous_71075191 |
source | Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list) |
subjects | Anti-Bacterial Agents - therapeutic use antibody Biological and medical sciences Chlamydia Infections - diagnosis Chlamydia Infections - drug therapy Chlamydia trachomatis Chlamydia trachomatis - immunology Endoscopy Enzyme-Linked Immunosorbent Assay - methods Fallopian Tube Diseases - epidemiology Fallopian Tube Diseases - microbiology Fallopian Tube Diseases - pathology Fallopian Tube Patency Tests Fallopian Tubes - pathology Female Fluorescent Antibody Technique, Indirect Genital system Humans hysterosalpingography Hysterosalpingography - methods Immunoglobulin G - blood Incidence Infertility, Female - epidemiology Infertility, Female - microbiology Infertility, Female - pathology Investigative techniques, diagnostic techniques (general aspects) Laparoscopy Medical sciences tubal damage |
title | The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A54%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20value%20of%20Chlamydia%20trachomatis%20antibody%20testing%20as%20part%20of%20routine%20infertility%20investigations&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Thomas,%20K.&rft.date=2000-05-01&rft.volume=15&rft.issue=5&rft.spage=1079&rft.epage=1082&rft.pages=1079-1082&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/15.5.1079&rft_dat=%3Cproquest_cross%3E71075191%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71075191&rft_id=info:pmid/10783356&rft_oup_id=10.1093/humrep/15.5.1079&rfr_iscdi=true |